Trusted Resources: Evidence & Education
Scientific literature and patient education texts
source: Family Practice Notebook
Eye complications occur in 25-50% of Grave’s disease.
Grave’s disease induced eye changes:
• Sensitized orbital tissue-specific T-Lymphocytes
• Local inflammatory cellular infiltration of eye
Orbital fibroblasts mediate changes:
• Adipose hypertrophy
• Glycosaminoglycan accumulates
Residual scarring may cause irreversible proptosis.
Tobacco abuse (Relative Risk 3.7)
Older men appear to have more severe cases
Radioiodine therapy may cause flare in eye disease
• Prednisone used to prevent flare
– Dose: 40 to 80 mg daily
– Taper off over 3 months.
Avoiding Grave Cardiac Outcomes in an Athlete with Grave’s DiseaseHistory: A 20-yr male college football ...
Long-Term Outcomes of Orbital Fat Decompression in Graves’ OrbitopathyPurpose: To evaluate the long-term clin...
Graves’ Orbitopathy as a Rare Disease in Europe: A European Group on Graves’ Orbitopathy (EUGOGO) Positi...Background: Graves' orbitopathy (GO) is...
British Thyroid Foundation’s Children’s ConferenceIf your child has a thyroid disorder, co...
Emotional Impact of Thyroid Eye Disease by Dr. Alon Kahanahttps://www.youtube.com/watch?v=2wHagc7T...
Teprotumumab Improves Short and Long-Term Clinical Outcomes in Thyroid Eye DiseaseMost adults with thyroid eye disease rec...
Clinical Characteristics of Patients Requiring a Second Dose of Radioactive Iodine for the Treatment of Graves’ Di...Graves’ disease is an autoimmune condi...
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.